Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion type Assertion NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_head.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion description "[The incidence of leukemia in these mice varied from 5% to 50%, dependent on the Cre-driving promoter (Cd19, Mb1, or Mx1) used to induce E2A-PBX1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_provenance.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion evidence source_evidence_literature NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_provenance.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion SIO_000772 26301816 NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_provenance.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion wasDerivedFrom befree-2016 NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_provenance.
- NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_assertion wasGeneratedBy ECO_0000203 NP1293125.RAcEF-gL8r3d-3S6UvnEDRojAEXvPumZnCEh9-TND-nvM130_provenance.